A detailed history of Panagora Asset Management Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 39,241 shares of FHTX stock, worth $193,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,241
Previous 98,527 60.17%
Holding current value
$193,458
Previous $566,000 35.51%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.8 - $9.99 $284,572 - $592,267
-59,286 Reduced 60.17%
39,241 $365,000
Q2 2024

Jul 29, 2024

SELL
$5.05 - $8.0 $8,978 - $14,224
-1,778 Reduced 1.77%
98,527 $566,000
Q1 2024

May 07, 2024

BUY
$2.82 - $7.94 $9,272 - $26,106
3,288 Added 3.39%
100,305 $673,000
Q4 2023

Feb 08, 2024

BUY
$2.94 - $6.76 $183,576 - $422,101
62,441 Added 180.59%
97,017 $625,000
Q3 2023

Oct 31, 2023

BUY
$5.0 - $9.87 $172,880 - $341,265
34,576 New
34,576 $172,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $205M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.